Fundraising Fox

Frank Longo

Scientific Advisory Board member — Former Chair, Stanford Dept. of Neurology and Neurological Sciences at Red Tree Venture

Stanford

About

Frank Longo earned his M.D. and Ph.D. in neuroscience from UC San Diego and completed his neurology residency and fellowship at UC San Francisco, where he later became professor and vice chair of the Department of Neurology. He chaired the Department of Neurology at UNC–Chapel Hill (2001-2005) and at Stanford University (2006-2023), where his laboratory studies mechanisms of neurodegenerative diseases and related translational research. He founded and serves as board chair of PharmatrophiX, a clinical-stage company developing small molecule therapeutics for neurodegenerative diseases, and sits on the NIH National Advisory Council on Aging.

Invests in

AI & Machine LearningBiotech

Investments

Board seats

PharmatrophiX

As listed on the firm's website.

Colleagues at Red Tree Venture

Adam Silverman
Red Tree Venture Labs Biologics at Red Tree Venture
Antonio Lepore
Senior Associate at Red Tree Venture
Ariell Ortega
Executive Assistant at Red Tree Venture
Bill Robinson
Scientific Advisory Board - Immunology; Chief, Stanford Division of Immunology and Rheumatology at Red Tree Venture
Brian Stearns
Red Tree Venture Labs Chemistry at Red Tree Venture
Cassie Lue
VP of Investor Relations at Red Tree Venture
Crystal Mackall
Scientific Advisory Board - Oncology; Director, Stanford Center for Cancer Cell Therapy at Red Tree Venture
Deborah Nguyen
Red Tree Venture Labs Operating Partner at Red Tree Venture